APA

Hsu P., Tsai F., Kao S., Hsu W., Cheng J., Peng N., Tsai K., Hu H., Wang Y., Chuah S., Chen A. & Wu D. (20170915). Ten-Day Quadruple Therapy Comprising Proton Pump Inhibitor, Bismuth, Tetracycline, and Levofloxacin is More Effective than Standard Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori Infection: A Randomized Controlled Trial. : The American journal of gastroenterology.

Chicago

Hsu Ping-I, Tsai Feng-Woei, Kao Sung-Shuo, Hsu Wen-Hung, Cheng Jin-Shiung, Peng Nan-Jing, Tsai Kuo-Wang, Hu Huang-Ming, Wang Yao-Kuang, Chuah Seng-Kee, Chen Angela and Wu Deng-Chyang. 20170915. Ten-Day Quadruple Therapy Comprising Proton Pump Inhibitor, Bismuth, Tetracycline, and Levofloxacin is More Effective than Standard Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori Infection: A Randomized Controlled Trial. : The American journal of gastroenterology.

Harvard

Hsu P., Tsai F., Kao S., Hsu W., Cheng J., Peng N., Tsai K., Hu H., Wang Y., Chuah S., Chen A. and Wu D. (20170915). Ten-Day Quadruple Therapy Comprising Proton Pump Inhibitor, Bismuth, Tetracycline, and Levofloxacin is More Effective than Standard Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori Infection: A Randomized Controlled Trial. : The American journal of gastroenterology.

MLA

Hsu Ping-I, Tsai Feng-Woei, Kao Sung-Shuo, Hsu Wen-Hung, Cheng Jin-Shiung, Peng Nan-Jing, Tsai Kuo-Wang, Hu Huang-Ming, Wang Yao-Kuang, Chuah Seng-Kee, Chen Angela and Wu Deng-Chyang. Ten-Day Quadruple Therapy Comprising Proton Pump Inhibitor, Bismuth, Tetracycline, and Levofloxacin is More Effective than Standard Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori Infection: A Randomized Controlled Trial. : The American journal of gastroenterology. 20170915.